Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

All hemoglobin-based oxygen carriers are not created equally.

Buehler PW, Alayash AI.

Biochim Biophys Acta. 2008 Oct;1784(10):1378-81. doi: 10.1016/j.bbapap.2007.12.009. Epub 2008 Jan 3. Review.

PMID:
18206989
2.

First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.

Alayash AI, D'Agnillo F, Buehler PW.

Expert Opin Biol Ther. 2007 May;7(5):665-75. Review.

PMID:
17477804
3.

Allosteric effects on oxidative and nitrosative reactions of cell-free hemoglobins.

Bonaventura C, Henkens R, Alayash AI, Crumbliss AL.

IUBMB Life. 2007 Aug-Sep;59(8-9):498-505. Review.

4.
5.

Polymeric nanoparticles for hemoglobin-based oxygen carriers.

Piras AM, Dessy A, Chiellini F, Chiellini E, Farina C, Ramelli M, Della Valle E.

Biochim Biophys Acta. 2008 Oct;1784(10):1454-61. doi: 10.1016/j.bbapap.2008.03.013. Epub 2008 Apr 11. Review.

PMID:
18452723
6.

Role of redox potential of hemoglobin-based oxygen carriers on methemoglobin reduction by plasma components.

Dorman SC, Kenny CF, Miller L, Hirsch RE, Harrington JP.

Artif Cells Blood Substit Immobil Biotechnol. 2002 Jan;30(1):39-51.

PMID:
12000225
7.

Cell-free oxygen carriers: scientific foundations, clinical development, and new directions.

Winslow RM.

Biochim Biophys Acta. 2008 Oct;1784(10):1382-6. doi: 10.1016/j.bbapap.2008.04.032. Epub 2008 May 21. Review.

PMID:
18555029
8.

[Hemoglobin-based oxygen carriers and trials to substitute red blood cells].

Smani Y, Labrude P, Vigneron C, Faivre B.

Transfus Clin Biol. 2007 Nov;14(5):464-73. doi: 10.1016/j.tracli.2007.12.007. Epub 2008 Mar 4. Review. French.

PMID:
18295525
9.

Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design.

Buehler PW, D'Agnillo F, Schaer DJ.

Trends Mol Med. 2010 Oct;16(10):447-57. doi: 10.1016/j.molmed.2010.07.006. Epub 2010 Aug 13. Review.

PMID:
20708968
10.

Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers.

Haney CR, Buehler PW, Gulati A.

Adv Drug Deliv Rev. 2000 Feb 28;40(3):153-69. Review.

PMID:
10837787
11.

Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components.

Harrington JP, Gonzalez Y, Hirsch RE.

Artif Cells Blood Substit Immobil Biotechnol. 2000 Nov;28(6):477-92.

PMID:
11063090
12.

Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of Hemoglobin-Based Oxygen Carriers (HBOC).

Cooper CE, Silaghi-Dumitrescu R, Rukengwa M, Alayash AI, Buehler PW.

Biochim Biophys Acta. 2008 Oct;1784(10):1415-20. doi: 10.1016/j.bbapap.2008.03.019. Epub 2008 Apr 16.

PMID:
18457681
13.

Consequences of chemical modifications on the free radical reactions of human hemoglobin.

Alayash AI, Fratantoni JC, Bonaventura C, Bonaventura J, Bucci E.

Arch Biochem Biophys. 1992 Oct;298(1):114-20.

PMID:
1524419
14.

Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Implications in the design of safer agents.

Osawa Y, Darbyshire JF, Meyer CA, Alayash AI.

Biochem Pharmacol. 1993 Dec 14;46(12):2299-305.

PMID:
8274164
15.

Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes.

Patel RP.

Free Radic Biol Med. 2000 May 15;28(10):1518-25. Review.

PMID:
10927176
16.

Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems.

Buehler PW, Alayash AI.

Transfusion. 2004 Oct;44(10):1516-30. Review.

PMID:
15383027
17.

Hemoglobin-based red blood cell substitutes and nitric oxide.

Yu B, Bloch KD, Zapol WM.

Trends Cardiovasc Med. 2009 Apr;19(3):103-7. doi: 10.1016/j.tcm.2009.06.004.

18.

A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter.

Bobofchak KM, Mito T, Texel SJ, Bellelli A, Nemoto M, Traystman RJ, Koehler RC, Brinigar WS, Fronticelli C.

Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H549-61. Epub 2003 Apr 10.

19.

Ligand reactivity and allosteric regulation of hemoglobin-based oxygen carriers.

Ronda L, Bruno S, Abbruzzetti S, Viappiani C, Bettati S.

Biochim Biophys Acta. 2008 Oct;1784(10):1365-77. doi: 10.1016/j.bbapap.2008.04.021. Epub 2008 May 4. Review.

PMID:
18502214
20.

Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity and renal filtration.

Portöro I, Kocsis L, Hermán P, Caccia D, Perrella M, Ronda L, Bruno S, Bettati S, Micalella C, Mozzarelli A, Varga A, Vas M, Lowe KC, Eke A.

Biochim Biophys Acta. 2008 Oct;1784(10):1402-9. doi: 10.1016/j.bbapap.2008.03.005. Epub 2008 Mar 20.

PMID:
18405674
Items per page

Supplemental Content

Write to the Help Desk